Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 305,136	$ 334,427
Marketable securities	6,528	7,439
Research and development tax credits receivable	2,986	2,580
Other receivables	663	654
Prepaid expenses	3,915	6,314
Total current assets	319,228	351,414
Property and equipment, net	5,397	5,604
Operating lease right-of-use assets	7,003	7,491
Other assets	586	586
Deferred tax assets	4,935	3,620
TOTAL ASSETS	337,149	368,715
CURRENT LIABILITIES:
Accounts payable	1,546	2,302
Accrued expenses and other current liabilities	16,936	18,622
Operating lease liability, current portion	1,857	1,721
Deferred revenue, current portion	11,874	11,921
Income tax payable	1,870	523
Total current liabilities	34,083	35,089
Operating lease liability, net of current portion	5,154	5,592
Deferred revenue, net of current portion	39,252	39,613
TOTAL LIABILITIES	78,489	80,294
SHAREHOLDERS’ EQUITY
Preferred shares, no par value per share; unlimited shares authorized as of September 30, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding as of September 30, 2021, and December 31, 2020, respectively	0	0
Common shares, no par value per share; unlimited shares authorized as of September 30, 2021 and December 31, 2020; 37,133,938 and 36,902,924 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	481,048	480,699
Additional paid-in capital	22,635	17,988
Accumulated deficit	(245,023)	(210,266)
Total shareholders’ equity	258,660	288,421
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 337,149	$ 368,715